Details

Autor(en) / Beteiligte

• Liu, Yunhua
• Hu, Xiaoxiao
• Han, Cecil
• Wang, Liana
• Zhang, Xinna
• He, Xiaoming
• Lu, Xiongbin

Titel

Targeting tumor suppressor genes for cancer therapy

Ist Teil von

• BioEssays, 2015-12, Vol.37 (12), p.1277-1286

Ort / Verlag

United States: Published for ICSU Press by Cambridge University Press

Erscheinungsjahr

2015

Link zum Volltext

Quelle

Wiley Online Library - AutoHoldings Journals

Beschreibungen/Notizen

• Cancer drugs are broadly classified into two categories: cytotoxic chemotherapies and targeted therapies that specifically modulate the activity of one or more proteins involved in cancer. Major advances have been achieved in targeted cancer therapies in the past few decades, which is ascribed to the increasing understanding of molecular mechanisms for cancer initiation and progression. Consequently, monoclonal antibodies and small molecules have been developed to interfere with a specific molecular oncogenic target. Targeting gain‐of‐function mutations, in general, has been productive. However, it has been a major challenge to use standard pharmacologic approaches to target loss‐of‐function mutations of tumor suppressor genes. Novel approaches, including synthetic lethality and collateral vulnerability screens, are now being developed to target gene defects in p53, PTEN, and BRCA1/2. Here, we review and summarize the recent findings in cancer genomics, drug development, and molecular cancer biology, which show promise in targeting tumor suppressors in cancer therapeutics.